| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | AD 8 ELISA Kit; AD8 ELISA Kit; Amyloid angiopathy and cerebral hemorrhage ELISA Kit; ARMD11 ELISA Kit; bA218C14.4 (cystatin C) ELISA Kit; bA218C14.4 ELISA Kit; Cst 3 ELISA Kit; Cst3 ELISA Kit; CST3 protein ELISA Kit; Cystatin 3 ELISA Kit; Cystatin-3 ELISA Kit; Cystatin-C ELISA Kit; Cystatin3 ELISA Kit; CystatinC ELISA Kit; CYTC_HUMAN ELISA Kit; Epididymis secretory protein Li 2 ELISA Kit; Gamma trace ELISA Kit; Gamma-trace ELISA Kit; HCCAA ELISA Kit; HEL S 2 ELISA Kit; MGC117328 ELISA Kit; Neuroendocrine basic polypeptide ELISA Kit; Post gamma globulin ELISA Kit; Post-gamma-globulin ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, urine, saliva, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Cystatin C (CST3) is a biological molecule commonly studied in cardiovascular research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P01034
Biological context
Researchers often monitor Cystatin C in serum, plasma, urine, and saliva to better understand themes such as vascular biology and endothelial function, cardiac remodeling and injury responses, and thrombosis and hemostasis. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Cystatin C may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, endothelial markers, coagulation-related proteins, and cardiac injury markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Cystatin C may also appear under names such as AD 8 and AD8. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Cystatin C participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Systematic Review of Kidney Injury Biomarkers for the Evaluation of CKD of Uncertain Etiology
SE Claudel,/,/
Bryostatin-1 Attenuates Ischemia-Elicited Neutrophil Transmigration and Ameliorates Graft Injury after Kidney Transplantation
F Becker,Cells,2022
Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats
W Wadie,Life Sciences,2021
Adequacy of Olmesartan monotherapy versus cotherapy in patients with essential hypertension
FH Rada,International Journal of Research in Pharmaceutical Sciences,2020
THE POSSIBLE ROLE OF RENALASE ENZYME IN CARDIOVASCULAR COMPLICATIONS IN CHRONIC KIDNEY DISEASE PATIENTS
ZAINAB A A AL-SHAMMA, et al,Asian Journal of Pharmaceutical and Clinical Research,2019
Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D)
F Dehghan.et al,Scientific Reports ,2016